These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 18543051)

  • 1. Histogenetic characterization of giant cell tumor of bone.
    Salerno M; Avnet S; Alberghini M; Giunti A; Baldini N
    Clin Orthop Relat Res; 2008 Sep; 466(9):2081-91. PubMed ID: 18543051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PTHrP increases RANKL expression by stromal cells from giant cell tumor of bone.
    Cowan RW; Singh G; Ghert M
    J Orthop Res; 2012 Jun; 30(6):877-84. PubMed ID: 22102368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Histogenesis of giant cell tumors].
    Wuelling M; Engels C; Jesse N; Werner M; Kaiser E; Delling G
    Pathologe; 2002 Sep; 23(5):332-9. PubMed ID: 12376858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigation of FGFR2-IIIC signaling via FGF-2 ligand for advancing GCT stromal cell differentiation.
    Singh S; Singh M; Mak IW; Turcotte R; Ghert M
    PLoS One; 2012; 7(10):e46769. PubMed ID: 23071632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for the role of matrix metalloproteinase-13 in bone resorption by giant cell tumor of bone.
    Mak IW; Seidlitz EP; Cowan RW; Turcotte RE; Popovic S; Wu WC; Singh G; Ghert M
    Hum Pathol; 2010 Sep; 41(9):1320-9. PubMed ID: 20573369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The origin of the neoplastic stromal cell in giant cell tumor of bone.
    Wülling M; Delling G; Kaiser E
    Hum Pathol; 2003 Oct; 34(10):983-93. PubMed ID: 14608531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recruitment of osteoclast precursors by stromal cell derived factor-1 (SDF-1) in giant cell tumor of bone.
    Liao TS; Yurgelun MB; Chang SS; Zhang HZ; Murakami K; Blaine TA; Parisien MV; Kim W; Winchester RJ; Lee FY
    J Orthop Res; 2005 Jan; 23(1):203-9. PubMed ID: 15607894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression and localization of extracellular matrix metalloproteinase inducer in giant cell tumor of bone.
    Si AI; Huang L; Xu J; Kumta SM; Wood D; Zheng MH
    J Cell Biochem; 2003 Aug; 89(6):1154-63. PubMed ID: 12898514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcriptional regulation of MMP-9 expression in stromal cells of human giant cell tumor of bone by tumor necrosis factor-alpha.
    Rao VH; Singh RK; Delimont DC; Finnell RH; Bridge JA; Neff JR; Garvin BP; Pickering DL; Sanger WG; Buehler BA; Schaefer GB
    Int J Oncol; 1999 Feb; 14(2):291-300. PubMed ID: 9917505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of TWIST as a regulator in giant cell tumor of bone.
    Singh S; Mak IW; Cowan RW; Turcotte R; Singh G; Ghert M
    J Cell Biochem; 2011 Sep; 112(9):2287-95. PubMed ID: 21503964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modern interpretation of giant cell tumor of bone: predominantly osteoclastogenic stromal tumor.
    Kim Y; Nizami S; Goto H; Lee FY
    Clin Orthop Surg; 2012 Jun; 4(2):107-16. PubMed ID: 22662295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bisphosphonates induce apoptosis of stromal tumor cells in giant cell tumor of bone.
    Cheng YY; Huang L; Lee KM; Xu JK; Zheng MH; Kumta SM
    Calcif Tissue Int; 2004 Jul; 75(1):71-7. PubMed ID: 15037971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene expression of monocyte chemoattractant protein-1 in giant cell tumors of bone osteoclastoma: possible involvement in CD68+ macrophage-like cell migration.
    Zheng MH; Fan Y; Smith A; Wysocki S; Papadimitriou JM; Wood DJ
    J Cell Biochem; 1998 Jul; 70(1):121-9. PubMed ID: 9632113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Osteoblast lineage properties in giant cell tumors of bone.
    Murata A; Fujita T; Kawahara N; Tsuchiya H; Tomita K
    J Orthop Sci; 2005 Nov; 10(6):581-8. PubMed ID: 16307183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Denosumab-treated Giant Cell Tumor of Bone Exhibits Morphologic Overlap With Malignant Giant Cell Tumor of Bone.
    Wojcik J; Rosenberg AE; Bredella MA; Choy E; Hornicek FJ; Nielsen GP; Deshpande V
    Am J Surg Pathol; 2016 Jan; 40(1):72-80. PubMed ID: 26414220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TGF-β induced PAR-1 expression promotes tumor progression and osteoclast differentiation in giant cell tumor of bone.
    Wang T; Jiao J; Zhang H; Zhou W; Li Z; Han S; Wang J; Yang X; Huang Q; Wu Z; Yan W; Xiao J
    Int J Cancer; 2017 Oct; 141(8):1630-1642. PubMed ID: 28670703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Giant cell tumor of bone. The role of fibroblast growth factor 3 positive mesenchymal stem cells in its pathogenesis.
    Robinson D; Segal M; Nevo Z
    Pathobiology; 2002-2003; 70(6):333-42. PubMed ID: 12865629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of osteoclast differentiation signals by stromal elements of giant cell tumors.
    Atkins GJ; Haynes DR; Graves SE; Evdokiou A; Hay S; Bouralexis S; Findlay DM
    J Bone Miner Res; 2000 Apr; 15(4):640-9. PubMed ID: 10780856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene expression of osteoprotegerin ligand, osteoprotegerin, and receptor activator of NF-kappaB in giant cell tumor of bone: possible involvement in tumor cell-induced osteoclast-like cell formation.
    Huang L; Xu J; Wood DJ; Zheng MH
    Am J Pathol; 2000 Mar; 156(3):761-7. PubMed ID: 10702390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parathyroid hormone-related protein (PTHrP) modulates adhesion, migration and invasion in bone tumor cells.
    Mak IW; Turcotte RE; Ghert M
    Bone; 2013 Jul; 55(1):198-207. PubMed ID: 23466453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.